本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Precision Biosciences Inc

5.33
-0.1700-3.09%
盤後5.330.00000.00%17:06 EDT
成交量:6.95萬
成交額:37.35萬
市值:5,586.87萬
市盈率:5.13
高:5.68
開:5.49
低:5.16
收:5.50
資料載入中...

公司資料

公司名字:
Precision Biosciences Inc
交易所:
NASDAQ
成立時間:
2006
員工人數:
108
公司地址:
302 East Pettigrew Street,Suite A-100,Durham,North Carolina,United States
郵編:
27701
電話:
傳真:
480 393 5553
簡介:
Precision BioSciences, Inc.在特拉華州註冊成立。該公司是一家先進的基因編輯公司,利用新型專有ARCUS平台開發用於複雜基因編輯的體內基因編輯療法,包括基因消除、插入和切除。

董事

名稱
職位
Matthew Kane
President, Chief Executive Officer and Director
Derek Jantz
Chief Scientific Officer and Director
Geno Germano
Independent Director
Kevin Buehler
Interim Chair of the Board, Independent Director
Raymond Schinazi
Independent Director
Shalini Sharp
Independent Director
Tony Yao
Independent Director

股東

名稱
職位
Fayaz Khazi
Chief Executive Officer, Elo Life Systems
Matthew Kane
President, Chief Executive Officer and Director
David Thomson
Chief Operating Officer
Abid Ansari
Chief Financial Officer
Christopher Heery
Chief Medical Officer
Dario Scimeca
General Counsel and Secretary
Derek Jantz
Chief Scientific Officer and Director